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Background: Cotinine levels provide a valid measure of exposure to environmental tobacco smoke (ETS). The goal
of this study was to examine exposure to tobacco smoke among smoking and nonsmoking Israeli adults and to
identify differences in ETS exposure among nonsmokers by socio-demographic factors.
Methods: We analyzed urinary cotinine data from the first Israeli human biomonitoring study conducted in 2011.
In-person questionnaires included data on socio-demographic and active smoking status. Cotinine levels were
measured using a gas chromatography–mass spectrometry procedure. We calculated creatinine-adjusted urinary
cotinine geometric means (GM) among smokers and nonsmokers, and by socio-demographic, smoking habits and
dietary factors. We analyzed associations, in a univariable and multivariable analysis, between socio-demographic
variables and proportions of urinary cotinine ≥1 μg/l (Limit of Quantification = LOQ) or ≥4 μg/l.
Results: Cotinine levels were significantly higher among 91 smokers (GM = 89.7 μg/g creatinine; 95% confidence
interval [CI]: 47.4-169.6) than among 148 nonsmokers (GM = 1.3; 1.1-1.7). Among exclusive waterpipe smokers,
cotinine levels were relatively high (GM = 53.4; 95% CI 12.3-232.7). ETS exposure was widespread as 62.2% of
nonsmokers had levels ≥ LOQ, and was higher in males (75.8%) than in females (52.3%). In a multivariable model,
urinary cotinine≥ LOQ was higher in males (Prevalence ratio [PR] = 1.30; 95% CI: 1.02-1.64, p = 0.032) and in those
with lower educational status (PR = 1.58; 1.04-2.38, p = 0.031) and decreased with age (PR = 0.99; 0.98-1.00, p = 0.020,
per one additional year). There were no significant differences by ethnicity, residence type or country of birth.
Conclusions: Our findings indicate widespread ETS exposure in the nonsmoking Israeli adult population, especially
among males, and younger and less educated participants. These findings demonstrate the importance of human
biomonitoring, were instrumental in expanding smoke-free legislation implemented in Israel on July 2012 and will
serve as a baseline to measure the impact of the new legislation.
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Environmental tobacco smoke (ETS) is a combination of
smoke emitted from a burning tobacco product and the
smoke exhaled by the smoker, which is also called sec-
ondhand smoke [1].
The adverse effects of ETS among nonsmoking adults
are well proven and mirror those associated with active
smoking [2]. ETS is causally associated with lung cancer
among never-smokers and among nonsmokers [3]. ETS
increases the risk of cardiovascular disease by approxi-
mately 30% [4], and also increases the risk of respiratory
diseases [5].
Various methods are available to measure ETS: self-
reporting, environmental measurements and human bio-
monitoring of various biomarkers in different biological
media [6]. Nicotine is a specific biomarker of exposure
to tobacco smoke, either active or ETS, but due to its
short half life (1-3 hours) it has limited value as a marker
of exposure. Cotinine, the primary proximate metabolite
of nicotine, is used most frequently as a biomarker of
tobacco smoke exposure, as its half-life is longer
(approximately 16-18 hours) and levels remain fairly
constant during the day. The cotinine level provides a
valid and quantitative measure of average recent human
ETS exposure and is therefore the preferred biomarker
of exposure to tobacco smoke in active smokers and in
nonsmokers exposed to ETS [7]. Dietary intake of nico-
tine from food like fruits and vegetables is possible but
likely to be negligible [8]. Urinary cotinine, especially
when corrected for creatinine concentration, is highly
correlated with plasma cotinine [9].
In Israel, according to the recent national survey, the
overall active smoking rate in the adult (21 years and
older) population, based on self-report, is 20.6% [10].
Smoking rates vary by sex and ethnicity: being highest
among Arab males (43.8%) and lower for Jewish males
(23.7%), Jewish females (15.9%) and Arab females (6.7%).
There was a recent study on ETS exposure in public
places in Israel based on air quality measurements [11].
However, assessment of ETS exposure of the Israeli popu-
lation by human biomonitoring has never been conducted,
thus the extent of exposure to ETS is unknown, both for
the entire population and for specific sub-groups.
The goal of this study was to examine exposure to
tobacco smoke among smoking and nonsmoking Israeli
adults and to identify differences in ETS exposure
among nonsmokers by socio-demographic factors, in
order to plan tobacco control activities and to serve as a
baseline for future monitoring.
Methods
Study design, settings and participants
The current study is based on the Israeli Human
Biomonitoring Study which was a cross-sectional studyon exposure of Israeli adults from the general population
to environmental chemicals and/or their metabolites, as
measured in urine samples. The primary objective of the
biomonitoring study was to provide information on ex-
posure to environmental chemicals in Israel in order to
support public health policy. Aims and methods of the
biomonitoring study are further detailed in our previous
publications [12,13].
The eligible population included Israeli adults, aged
20-74, aiming to represent the Israeli non-institutional-
ized adult population. Recruitment, interviewing and
sampling took place between February and June 2011.
The potential sample size was 300 individuals, assuming
up to 20% of missing data, incomplete questionnaires
and invalid urine samples, to reach a planned sample
size of 250 individuals. The parameters for defining the
sample were selected so as to represent the population
distribution of urban versus rural dwelling (with urban
defined as population more than 2,000) and the two
major ethnic groups in Israel (Jews and Arabs) as well
as wide geographical representation. Overall, 20 cities/
towns were selected, with 4 within the Arab sector
(3 urban, 1 rural) and 16 within the Jewish sector
(15 urban, 1 rural), representing the relative proportion
of the ethnic groups in Israel. In each city/town, inter-
viewers were requested to interview 15 people. Within
each city/town, interviewers were required to select 5
separate areas. Within each area, recruitment was done
by “knocking on doors” and interviewing those who met
the inclusion criteria and agreed to participate, including
providing a urine sample. The inclusion criteria were
age (20–74) and ability to answer the questionnaire in
Hebrew or Arabic. The response rate was 29%, excluding
individuals not eligible for the study and individuals not
at home at the time of the visit. People refusing partici-
pation were replaced by “knocking on the next door”.
Participants were not targeted for specific health status
and were not included or excluded on the basis of their
potential for low or high exposures to environmental
chemicals including tobacco exposure. Of 249 partici-
pants eventually included in the biomonitoring study,
one was excluded from the present report due to a miss-
ing cotinine value.
The study was conducted in accordance with the eth-
ical principles of the Declaration of Helsinki. The study
protocol was reviewed and approved by the Sheba Tel
Hashomer Helsinki Committee. Written informed con-
sent was obtained for all respondents. Participation in
the study was voluntary. At the time of recruitment par-
ticipants received a note explaining that they would re-
ceive individual results on urinary concentrations of
environmental contaminants if they requested it during
their interview or if their individual urinary metabolite
results were unusual (more than 10 times the 90th
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ceiving results were invited to contact the study coordin-
ator for additional information. All analysis of data for
the study was conducted without details on the identity
of the participants.
Data sources and variables
Study participants were interviewed using a structured
questionnaire. The interviews were administered by
trained interviewers. The interview consisted of a health
and lifestyle questionnaire, including smoking habits,
demographic questionnaire, a 24 hour dietary recall and
a food frequency questionnaire. All completed question-
naires were returned to the Israel Center for Disease
Control for data entry, quality assurance and analysis.
Socio-demographic and personal variables included age
(analyzed as a continuous variable, and also grouped as
“younger”, 20-44 years, and “older” 45-74 years), sex
(males/females), urbanicity (urban/rural), country of
birth (Israel/other), education (lower education [high
school level qualification or below]/higher education),
and ethnicity (Jewish/Arab). Druze were grouped with
Arab ethnicity. Twelve individuals had missing data for
country of birth and four individuals had ethnicity other
than Jewish or Arab, therefore they were excluded from
the univariable analysis.
Smoking status was based on self-report. Questions
used for active tobacco smoking status were: “Do you
currently smoke, including hookah (water pipe)?”, “What
do you currently smoke, or what did you smoke before?
(cigarettes, cigars, pipe, waterpipe, other)”, “How many
cigarettes do you smoke per day or per week?” Based on
the first question, participants were classified as tobacco
smokers (of any kind) or nonsmokers. Active smoking
variables were smoking type (cigarettes or cigarettes
and other forms/exclusive waterpipe/cigars or pipe) and
cigarette smoking frequency (<10 cigarettes/day, 10-20
cigarettes/day, >20 cigarettes/day).
Urine spot samples were collected in 120-ml urine
specimen containers. All urine samples were maintained
at below 4°C for a maximum of 24 hours until they
were transported to the Sheba Medical Center at Tel
Hashomer. Urine samples were aliquoted at Sheba
Medical Center and frozen at −20°C. Within four
months of collection, urine samples were shipped to the
University of Erlangen–Nuremberg in Germany on dry
ice (−70°C), where they were analyzed.
Laboratory analyses of cotinine and creatinine were
performed at the Institute and Outpatient Clinic of
Occupational, Social and Environmental Medicine,
University Erlangen-Nuremberg in Germany. Cotinine
in urine was determined using a gas chromatography
mass spectrometry procedure validated and published by
the working group “Analyses in biological materials”[14]. In brief, cotinine was extracted from the urine
using dichloromethane and quantified after gas chroma-
tographic separation by mass spectrometry in single ion
monitoring mode [15]. Deuterated cotinine was used as
an internal standard. Calibration was performed using
calibration standards which were prepared in pooled
non-smoker urine and which were treated in the same
manner as the samples to be analyzed. Limit of detection
is 0.5 μg/liter and limit of quantification (LOQ) is 1 μg/
liter. Limit of detection and limit of quantification were
calculated based on a signal-to-noise ratio of 1 to 3 and
1 to 6, respectively. Urinary analyte concentrations were
provided in units of μg/liter. These concentrations were
divided by urinary creatinine concentrations (g creatin-
ine/l urine) to generate creatinine-adjusted analyte con-
centrations. Creatinine in urine was determined by
photometric detection as picrate according to the Jaffé
method [16]. Quality control was performed by analys-
ing aliquots of control material in each series and accur-
acy was validated by the successful participation in
G-EQUAS for both parameters [17]. Concentrations
below the LOQ for an analyte were replaced by the limit
of detection (LOD). The main outcome variable was pro-
portion ≥ LOQ. Secondary outcome was geometric mean
(GM) of cotinine concentration adjusted for creatinine.
Statistical methods
Characteristics of the study population and by smoking
status were described by proportion for categorical vari-
ables and mean and standard deviation (SD) for continu-
ous variables. Characteristics were compared between
smokers and nonsmokers by Chi-Square or Fisher’s
Exact test for categorical variables, and by t-test for con-
tinuous variables. GM and 95% confidence intervals (CI)
were calculated for urinary creatinine-adjusted cotinine
concentrations and compared between smokers and
nonsmokers and between sub-groups of smokers and
nonsmokers using the t-test procedure for ratio using
the lognormal distribution.
Proportions of participants with cotinine levels ≥1 μg/l
(LOQ) or among nonsmokers were described overall
and by socio-demographic characteristics. We used the
Chi-Square or Fisher’s Exact Test to compare the pro-
portion of cotinine levels ≥ LOQ by socio-demographic
characteristics. Associations between continuous vari-
ables such as age to creatinine-adjusted urinary cotinine
among nonsmokers were assessed by Spearman correl-
ation. Multivariable analysis was conducted using
log-binomial regression with ≥ LOQ proportion as the
outcome of interest and all significant (at p < 0.05) vari-
ables were introduced to the model. Similar univariable
and multivariable analyses were conducted by a cut-off
of ≥4 μg/l, representing higher ETS exposure, allowing
comparison to a previous study in the German
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ent cut-off of 1.1 μg/l, allowing comparison with the
Canadian Human Biomonitoring Study [19]. Prevalence
ratio (PR) was used as a measure of association in all the
analyses with p < 0.05 considered significant. To allow
for comparison with other studies we calculated the
odds ratio (OR) by logistic regression model as well,
though the OR is expected to overestimate an effect due
to the high prevalence of the outcome in the study
(≥ LOQ proportion). All analyses were performed with
SAS 9.2 (SAS Institute Inc., Cary, NC, USA).
Results
The 248 study participants were divided into non-
smokers (n = 148) and smokers (n = 91) as 4 participants
were excluded due to unverified smoking status and
5 additional participants were excluded due to discrep-
ancy between self-reported smoking status as “non-
smokers” and creatinine-adjusted levels of cotinine
>150 μg/g [20]. The average age of 148 nonsmokers
(39.8 years, SD = 13.3) was significantly (p = 0.015)
higher than that of the 91 smokers (36.0 years,
SD = 10.8). Nonsmokers included a lower proportion of
males (41.9% vs. 63.7%), Jewish ethnicity (69.7% vs.
83.3%) and rural residence (7.4% vs. 17.6%) compared to
smokers (see Table 1).
All participants, smokers and nonsmokers, had urinary
cotinine levels > LOD. The distribution of cotinine con-
centration levels (μg/liter) among smokers and non-
smokers reflects clear differences (see Figure 1). Urinary
cotinine concentrations were significantly higher amongTable 1 Characteristics of total study population and by smok
Total study populationa
(N = 248)
Characteristic N % of total
Age (years) 20-44 164 66.1
45-74 84 33.9
Sex Males 127 51.2
Females 121 48.8
Ethnicity Jewish 184 74.2
Arab 64 25.8
Urbanicity Urban 218 87.9
Rural 30 12.1
Country of birth Israel 214 90.7
Other 22 9.3
Education Lower education 189 76.2
Higher education 55 22.5
*For difference in characteristics between smokers and nonsmokers, significance de
aData were missing for Country of Birth (12 participants) and Education (4 participa
ethnicity analysis.
bThe smoking status could not be verified for 4 participants in the study -who were
due to discrepancy between self-reported smoking status as “non-smokers” and cresmokers (GM = 89.7 μg/g creatinine; 47.4-169.6) than
among nonsmokers (GM = 1.3; 1.1-1.7). Among the
smokers, the majority (84.6%) smoked cigarettes (or cig-
arettes and other forms) and the minority were exclusive
waterpipe users (14.3%) or cigar smokers and pipe users
(1.1%). Cotinine levels were significantly higher among
smokers who reported >20 cigarettes/day (GM = 328.2;
67.7-1591.7, PR = 5.86; 95% CI 1.11-30.85, p = 0.040) as
compared to smokers who reported <10 cigarettes/day
(GM = 53.0; 18.3-153.0), and not significantly higher as
compared to those who reported 10–20 cigarettes/day
(GM = 73.5; 22.3-242.9). Among the group of exclusive
waterpipe smokers, all had levels above LOQ and cotin-
ine levels were relatively high (GM = 53.4; 95% CI 12.3-
232.7) and not significantly different than in cigarette
smokers (GM = 89.3; 42.5-187.6).
Among the nonsmokers, 62.2% had levels ≥ LOQ and
16.2% had levels ≥4 μg/l (see Table 2). Proportions ≥
LOQ were significantly higher for males compared to fe-
males (75.8% vs. 52.3%, p = 0.003) and among subjects
with lower education level compared to higher education
level (69.4% vs. 42.4%, p = 0.021). In the younger age
group (20-44 years), 67.8% had levels ≥ LOQ compared
to 53.5% for the older age group (45-74 years, p = 0.096);
there was a significant inverse association with age as a
continuous variable (PR = 0.99; 95% CI 0.98-1.00, per
one additional year, p = 0.022)., There was a tendency for
a higher proportion of nonsmokers with cotinine levels
above a cut-off point of ≥4 μg/l by education status
(20.7% vs. 3.0%, p = 0.055) and by sex (22.6% vs. 11.6%,
p = 0.08).ing status, Israel human biomonitoring study, 2011
Non-smokersb Smokers p-value*
(N = 148) (N = 91)
N % of total N % of total
90 60.8 68 74.7 0.027
58 39.2 23 25.3
62 41.9 58 63.7 0.001
86 58.1 33 36.3
101 69.7 75 83.3 0.019
44 30.3 15 16.7
137 92.6 75 82.4 0.016
11 7.4 16 17.6
129 90.2 77 90.6 0.925
14 9.8 8 9.4
111 77.1 72 79.1 0.714
33 22.9 19 20.9
termined using Chi-Square or Fisher’s Exact test.
nts). 4 participants were not Jewish or Arabs and were excluded from
excluded from further analysis. 5 participants were excluded from the analysis
atinine-adjusted levels of cotinine > 150 μg/g.
Cotinine Concentrations, µg/L, log scale
Figure 1 Distribution of urinary cotinine concentrations in Israeli smokers (n = 91) and non-smokers* (n = 153), Israel human
biomonitoring study, 2011. Limit of quantification appears as dashed line. *Five nonsmoker participants with creatinine-adjusted cotinine
concentrations >150 μg/g were excluded from further analysis.
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LOQ or ≥4 μg/l or the GM by country of birth, ethni-
city or urbanicity.
In a mutually adjusted model (see Table 3), urinary co-
tinine proportion ≥ LOQ remained associated with being
male (PR = 1.30; 95% CI: 1.02-1.64, p = 0.032), inversely
associated with age (PR = 0.99; 0.98-1.00, p = 0.020, per
one additional year) and associated with having lower
educational status (PR = 1.58; 1.04-2.38, p = 0.031). The
inference based on the OR estimates in a mutually
adjusted logistic regression model was similar to the
finding of a log-binomial model, but as expected overes-
timated the magnitude of associations, i.e. male (OR =
2.56; 95% CI: 1.18-5.55), younger age (OR = 0.96; 0.94-
0.99, per one additional year) and lower education
(OR = 3.25; 1.39-7.59).
As a sensitivity analysis, we further excluded 5 partici-
pants with self-reported smoking status as nonsmokers
and creatinine-adjusted levels of cotinine >50 μg/g (but
<150 μg/g). Findings were similar in the mutually ad-
justed model: associated with being male (PR = 1.28; 95%
CI: 1.00-1.63, p = 0.048), inversely associated with age
(PR = 0.99; 0.98-1.00, p = 0.014, per one additional year)
and associated with having lower educational status
(PR = 1.55; 1.03-2.35, p = 0.037).Discussion
The present study, the first to evaluate exposure to to-
bacco smoke using a biological marker in an Israeli gen-
eral population, demonstrates widespread and high ETS
exposure in the non-smoking adult population in Israel.
Despite limited power due to small sample size, ETS ex-
posure was found to be significantly more common
among males, younger study participants and those with
lower education.
We found clear differences in urinary cotinine levels be-
tween smokers and nonsmokers, with higher levels by
smoking frequency. This expected finding gives some val-
idation to our study methods such as data collection and
laboratory analysis. Cotinine levels among exclusive water-
pipe users were similar to those in cigarette smokers, in
line with known limited data indicating that daily use of
waterpipe produces nicotine absorption of a magnitude
similar to that produced by daily cigarette use [21]. This
observation gives further evidence to the addictive poten-
tial of this common habit in our population. There is a
gradual increase in evidence related to the harmful effects
of waterpipe smoking, as was suggested by our previous
findings in Israel [22]. The effects of waterpipe passive
smoking are largely unknown, although a recent Israeli
study showed some physiological effects [23].
Table 2 Associations of socio-demographic factors with creatinine-adjusted cotinine concentrations in Israeli nonsmoking adults,
Israel human biomonitoring study, 2011 (N = 148)




% (n/N)a,b % (n/N)a
All 62.2 (92/148) 16.2 (24/148) 1.33 1.06–1.67
Age (years) 20–44 67.8 (61/90) Ref. 15.6 (14/90) Ref. 1.27 0.95–1.68
45–74 53.5 (31/58) 0.70 (0.60; 1.04) 0.096 17.2 (10/58) 1.11(0.53; 2.33) 0.786 1.42 0.96–2.12
Sex Males 75.8 (47/62) 1.45 (1.13; 1.85) 0.003 22.6 (14/62) 1.94 (0.92; 4.08) 0.080 1.65 1.10–2.48
Females 52.3 (45/86) Ref. 11.6 (10/86) Ref. 1.13 0.87–1.48
Ethnicity Jewish 65.4 (66/101) 1.18 (0.88; 1.58) 0.266 17.8 (18/101) 1.40 (0.59; 3.29) 0.455 1.39 1.06–1.83
Arab 52.3 (23/44) Ref. 13.6 (6/44) Ref. 1.17 0.73–1.86
Residence type Urban 62.0 (85/137) Ref. 15.3 (21/137) Ref. 1.30 1.04–1.63
Rural 63.6 (7/11) 1.03 (0.64; 1.63) 0.915 27.3 (3/11) 1.78 (0.63; 5.05) 0.279 1.69 0.38–7.52
Country of birth Israel 59.7 (77/129) Ref. 14.7 (19/129) Ref. 1.23 0.97–1.56
Other 71.4 (10/14) 1.20 (0.83; 1.72) 0.329 14.3 (2/14) 0.97 (0.25; 3.74) 0.965 1.36 0.77–2.41
Education Lower education 69.4 (77/111) 1.64 (1.08; 2.48) 0.021 20.7 (23/111) 6.84 (0.96; 48.74) 0.055 1.58 1.20–2.07
Higher education 42.4 (14/33) Ref. 3.0 (1/33) Ref. 0.79 0.53–1.19
*Significance levels are based on Univariable log-binomial regression, compared to reference level.
aFor each variable category, the proportion is given as well as, in parentheses, the number of participants above the cut-off (n) and the total number of participants in the category (N).



















Table 3 Associations of socio-demographic factors with
urinary cotinine levels ≥ LOQa (1 μg/l) in Israeli
nonsmoking adults (n = 144), multi-variable log-binomial
regression model, Israel human biomonitoring study,
2011
Parameter p-value PR (95% CI)
Males vs. Females 0.032 1.30 (1.02; 1.64)
Age, in years (per one additional year) 0.020 0.99 (0.98; 1.00)
Lower education vs. higher education 0.031 1.58 (1.04; 2.38)
aCI, Confidence interval; LOQ, Limit of quantification; PR, Prevalence ratio.
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tinine above LOD, 62.2% had levels ≥1 μg/liter and
16.2% had levels ≥4 μg/liter. Our results are comparable
to those in a previous study conducted in the German
population in 1998, which found urinary cotinine levels
≥4 μg/liter in 23% of the nonsmokers and even higher in
males (26%) as compared to females (19%) [18]. In a re-
cent study in the Canadian general population 15% of
those aged 20-39 years and 11% of those aged 40-59
years had urinary cotinine levels >1.1 μg/liter [19]. In
our population, using the same cut-off, rates were at
least four times higher in both age groups (67% and
45%, respectively). Median or geometric mean levels
could not be compared as those were not reported in
the Canadian or German studies due to a high propor-
tion below the LOD, while in our study all nonsmokers
had levels above LOD. In a finding similar to that in our
study, widespread ETS exposure was previously found
among nonsmokers in another Middle-Eastern country–
Syria [24]. In that study, a moderate correlation was
found between salivary cotinine levels and self-reported
exposure measures such as house smoking policy. Our
study gives further evidence to the widespread and high
level of ETS exposure in the Middle East region.
The proportion of population exposed to ETS in our
study, based on urinary cotinine concentrations ≥ LOQ,
was much higher in males compared to females, a find-
ing consistent with previous studies in the adult popula-
tion [18,19,25,26]. Lower education and younger age
were also important risk factors for exposure and
remained so after mutual adjustment, consistent with
studies in other countries [26-29].
In order to supplement our study, we analyzed data on
self-reported ETS among nonsmokers, based on the
2010 Israel Central Bureau of Statistics Social Survey
[30]. The survey was conducted by interviewing ~7500
Israelis during 2010, a random sample of the adult Israeli
population. In this survey, 69.3% of nonsmokers aged
20-74 reported exposure to ETS, higher (74.3%) for
males compared to females (65.5%). Among those who
reported exposure, 33.6% reported ETS at the workplace,
26.8% at home, and 77.3% in other places. A much
higher percentage of males reported ETS at work(46.7%) than females (22.3%). In contrast, a higher pro-
portion of females reported ETS at home (35.4%) com-
pared with males (16.8%). This analysis gives further
evidence to the widespread ETS exposure in the Israeli
population found in our study. Additional support for
widespread ETS exposure stems from a study conducted
among Israeli adolescents, based on self-reported expos-
ure [31].
Public health and health promotion efforts regarding
tobacco smoke exposure should be directed to the young
male population, as not only are active smoking rates
high, but ETS is also high and common among non-
smokers in this population. This group needs tailored in-
terventions, to address social needs as well as attitudes
to ETS which may include more tolerance to exposure
at work.
The main finding of the study, widespread and high
ETS in all groups of the Israeli population, has served to
raise support and political will for taking further steps to
reduce ETS in the public and private arenas in Israel.
The present study was instrumental in expanding
smoke-free legislation implemented in Israel in July
2012. This new legislation included prohibition of smok-
ing, for the first time, in open spaces such as outside en-
trances to health facilities, railway platforms, etc. [32].
There are major problems in implementation of
smoke-free legislation in bars and pubs in Israel due to
social norms [33], despite the fact that the majority
(67%) of Israelis support completely smoke-free bars and
pubs, according to a previous survey [34]. The new
popular trend of e-cigarettes (battery-operated products
that deliver nicotine, flavor and other chemicals via a
vapor that is inhaled by the user) in Israel and elsewhere
should be taken into account when planning tobacco
control policy, as it may reduce ETS but may give legit-
imacy to smoking in public places [35]. There is evi-
dence that mobile health (m-Health) efforts for smoking
cessation can be effective and mobile phones should be
explored as a method for preventing ETS as well [36].
We are currently developing a text messaging program
for Israeli smokers as well as a mobile phone application
for reporting violations of the smoke-free law in public
places in Israel.
National human biomonitoring studies on ETS expos-
ure using cotinine measurements have been used by
other countries to demonstrate the positive effects of
smoke-free legislation and identify its impact on differ-
ent population groups [25,26]. Cotinine biomonitoring
in the general population is an important tool for to-
bacco control. Conducting national biomonitoring pro-
grams can be used to determine the average (and range
of ) ETS, establish baseline levels of exposure and assess
trends over time, provide information for directing pub-
lic health priorities for environmental health policy,
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identify potentially vulnerable groups. Urinary cotinine
monitoring can also be used to evaluate the success of
public health interventions. Such programs exist in the
United States, Canada, Belgium, France, Germany and
the European Union. Active tobacco smoking and ETS
are important exposures in themselves, as well as con-
founders/mediators in many other environmental expo-
sures, and should be assessed in depth in any national
human biomonitoring program. We plan to conduct a
follow up biomonitoring study in Israel in 2015 on ex-
posure to ETS (as well as pesticides) in Israel, in order
to determine whether the policies described above have
been effective in reducing public exposure to ETS in the
general population.
Two major strengths of the current study include the
representation of a wide geographical distribution and
different socio-demographic groups and the use of a
valid, sensitive and accurate quantitative biochemical as-
sessment of ETS. Cotinine was shown in the past to be
derived from exposure to tobacco smoking, while other
sources, such as dietary sources, were shown to be negli-
gible [8]. Indeed, we did not find an association between
urinary cotinine and fruits or vegetables consumption in
our population (data not shown).
Nonetheless, some limitations of the study should be
considered. An important methodological limitation of
the study is the “convenient” non-random sampling
technique. It is not certain to what extent the study
population is representative of the general adult popula-
tion in Israel. For example, the Arab population was
over-represented in the study (25%) compared to 18% in
the Israeli population of the same age [37]. Hence, inter-
pretation of the findings should be done cautiously,
although selection bias is an unlikely explanation for the
widespread high ETS exposure found. A second limita-
tion of our study is the lack of self-reported ETS status
and sources, which could have helped in elaboration of
ETS patterns. However, urinary cotinine levels give bet-
ter estimates of ETS and we were able to confirm our
findings by data from the 2010 Social Survey. Another
limitation is the possibility of that cotinine levels found
in our nonsmoking population derived not only from
ETS, but, in some cases, from misclassification of smok-
ing status or use of nicotine replacement therapy as a
source of exposure. We minimized this possibility by ex-
clusion of those with cotinine levels >150 μg/g and by
our sensitivity analysis further excluding cotinine levels
>50 μg/g. Unfortunately, we did not collect data on time
elapsed since last cigarette smoked among self-reported
smokers which might explain why some self-reported
smokers (who did not smoke recently) had relatively low
urinary cotinine levels as well as the higher smoking rate
in our study population compared to the general Israeliadult population. Self-reported smoking status is consid-
ered valid, especially for those aged 20 and above [38],
so it is unlikely that misclassification by smoking status
significantly affected our results. Finally, our relatively
small sample size gives limited power to identify differ-
ences in magnitude of exposure as expressed by GM, or
between specific sub-groups such as those based on
ethnicity.
Conclusions
This study shows widespread ETS exposure in the non-
smoking adult Israeli population, especially among
males, the younger population and those with lower
education. These findings demonstrate the importance
of human biomonitoring, were instrumental in expand-
ing smoke-free legislation implemented in Israel on July
2012 and will serve as a baseline to measure the impact
of the new legislation.
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